News Releases :: Sutro Biopharma, Inc. (STRO)

Sep 3, 2020 7:00 am EDT

Sutro Biopharma to Present at Two Upcoming Investor Conferences

Sep 2, 2020 4:12 pm EDT

Sutro Biopharma Announces Promising STRO-002 Interim Phase 1 Clinical Data in Ovarian Cancer and Presentation at the 2020 IGCS Annual Global Meeting

Aug 25, 2020 7:00 am EDT

Sutro Biopharma Earns Clinical Supply Milestone Payment from Merck KGaA, Darmstadt, Germany for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors

Aug 11, 2020 7:00 am EDT

Sutro Biopharma Announces Two Executive Promotions to Vice President of Quality and Vice President of Manufacturing

Aug 10, 2020 5:00 pm EDT

Sutro Biopharma to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

Aug 6, 2020 7:00 am EDT

Sutro Biopharma Reports Second Quarter 2020 Financial Results and Provides Business Highlights and Developments

Jun 22, 2020 7:00 am EDT

Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity

Jun 9, 2020 7:00 am EDT

Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020

May 21, 2020 7:15 am EDT

Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller

May 21, 2020 7:00 am EDT

Sutro Biopharma Adds Two Exceptional Leaders to Advisory Boards-- Carlos Paya, MD, PhD, and Lainie Martin, MD